The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study (vol 57, pg 123, 2010)

被引:6
|
作者
Roehrborn, Claus G. [1 ]
Siami, Paul [2 ]
Barkin, Jack [3 ]
Damiao, Ronaldo [4 ]
Major-Walker, Kim [5 ]
Nandy, Indrani [5 ]
Morrill, Betsy B. [5 ]
Gagnier, R. Paul [5 ]
Montorsi, Francesco [6 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[2] Deaconess Clin, Evansville, IN USA
[3] Univ Toronto, Dept Urol, Toronto, ON, Canada
[4] Univ Estado Rio De Janeiro, Dept Urol, Rio De Janeiro, Brazil
[5] GlaxoSmithKline Inc, Res & Dev, Res Triangle Pk, NC USA
[6] Univ Vita Salute San Raffaele, Dept Urol, Milan, Italy
关键词
D O I
10.1016/j.eururo.2010.07.035
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:801 / 801
页数:1
相关论文
共 49 条
  • [41] Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo-controlled study
    Rosen, Raymond C.
    Roehrborn, Claus G.
    Manyak, Michael J.
    Manuel Palacios-Moreno, Juan
    Wilson, Timothy H.
    Lulic, Zrinka
    Giuliano, Francois
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (09) : 1 - 9
  • [42] Three-Year Treatment Outcomes of Water Vapor Thermal Therapy Compared to Doxazosin, Finasteride and Combination Drug Therapy in Men with Benign Prostatic Hyperplasia: Cohort Data from the MTOPS Trial
    Gupta, Nikhil
    Rogers, Tyson
    Holland, Bradley
    Helo, Sevann
    Dynda, Danuta
    McVary, Kevin T.
    [J]. JOURNAL OF UROLOGY, 2018, 200 (02): : 405 - 413
  • [43] Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study
    Herschorn, Sender
    McVary, Kevin T.
    Santos, Javier Cambronero
    Foley, Steve
    Kristy, Rita M.
    Choudhury, Nurul
    Hairston, John
    Kaplan, Steven A.
    [J]. UROLOGY, 2021, 147 : 235 - 242
  • [44] IMPACT OF EARLY VS. DELAYED INITIATION OF DUTASTERIDE/TAMSULOSIN COMBINATION THERAPY IN LOWER URINARY TRACT SYMPTOMS/BENIGN PROSTATIC HYPERPLASIA (LUTS/BPH) PATIENTS WITH MODERATE TO SEVERE SYMPTOMS AT RISK FOR PROGRESSION: RESULTS FROM CLINICAL TRIAL SIMULATIONS USING RISK OF RETENTION OR SURGERY
    Roehrborn, Claus
    D'Agate, Salvatore
    Chavan, Chandrashekhar
    Manyak, Michael
    Palacios-Moreno, Juan Manuel
    Oelke, Matthias
    Michel, Martin C.
    Della Pasqua, Oscar
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E704 - E705
  • [45] Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo-controlled study
    Roehrborn, Claus G.
    Rosen, Raymond C.
    Manyak, Michael J.
    Manuel Palacios-Moreno, Juan
    Wilson, Timothy H.
    Lulic, Zrinka
    Giuliano, Francois
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2020, 74 (05)
  • [46] A 5-Year Study of 5α-Reductase Inhibitors in Men with Benign Prostatic Hyperplasia: Finasteride Has Comparable Urinary Symptom Efficacy and Prostate Volume Reduction But Less Sexual Side Effects and Breast Complications than Dutasteride (vol 66, pg 1052, 2012)
    Kaplan, S. A.
    Chung, D. E.
    Lee, R. K.
    Scofield, S.
    Te, A. E.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (03) : 291 - 291
  • [47] Factors associated with achieving minimally symptomatic status by patients with schizophrenia: results from the 3-year intercontinental schizophrenia outpatients health outcomes study (vol 64, pg 697, 2010)
    Treuer, T.
    Martenyi, F.
    Saylan, M.
    Dyachkova, Y.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (10) : 1459 - 1459
  • [48] Effects of tadalafil (TAD) or tamsulosin (TAM) on erectile function in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): Results from a multicenter, double-blind, randomized, placebo (PLA)-controlled 12-week study
    Giuliano, F.
    Oelke, M.
    Mirone, V
    Watts, S.
    Cox, D.
    Viktrup, L.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E705 - U503
  • [49] Safety and Effectiveness of Once-Daily Tadalafil (5 mg) Therapy in Korean Men with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms in a Real-World Clinical Setting: Results from a Post-Marketing Surveillance Study
    Won, Ji Eon
    Chu, Ji Yeon
    Choi, Hyunah Caroline
    Chen, Yun
    Park, Hyun Jun
    Duenas, Hector Jose
    [J]. WORLD JOURNAL OF MENS HEALTH, 2018, 36 (02): : 161 - 170